Company Filing History:
Years Active: 2006-2012
Title: **Innovative Contributions of Louis G. Keith in Breast Cancer Detection**
Introduction
Louis G. Keith, an inventive mind based in Chicago, IL, has significantly impacted the medical field with his contributions to breast cancer detection technologies. With a portfolio of five patents, his work primarily focuses on advanced thermal data analysis systems designed to identify suspect breast tissue conditions.
Latest Patents
Among his latest innovations are two patents that introduce a groundbreaking system for analyzing thermal data based on breast surface temperature. These patents describe a portable computing device equipped with temperature sensors capable of collecting precise temperature readings of breast tissue over regular intervals. The device is carefully designed to focus on the critical areas where breast cancers are most likely to develop. Utilizing a uniquely shaped sensor placeholder, which aligns with the glandular regions of the breast, the temperature data collected is then classified as suspect or non-suspect tissue using advanced classifier systems.
Career Highlights
Louis G. Keith's tenure at Lifeline Biotechnologies, Inc. is marked by his commitment to innovating medical technology, particularly in women's health. His work on analyzing breast surface temperature offers a proactive approach to early cancer detection, potentially saving countless lives through timely intervention.
Collaborations
Collaborating with talented professionals such as William H. Reeves and Jimmy D. Holmes, Keith has contributed to creating a multi-disciplinary team dedicated to pushing the boundaries of medical technology. These collaborations further enhance the potential impact of his inventions in clinical applications.
Conclusion
Louis G. Keith exemplifies the spirit of innovation in the medical device industry. His patents not only showcase significant advancements in thermal data analysis but also emphasize the importance of early diagnosis in breast cancer. With his continued efforts and collaborations, Keith is poised to drive further developments that could transform breast cancer detection and patient care.